Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024
Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024
-
World Rank (Jan-05-2024)10,291Market Cap (Jan-05-2024)0.733 Billion USDWorld Rank (Jul-30-2023)15,099Market Cap (Jul-30-2023)0.343 Billion USDWorld Rank (Dec-25-2022)21,255Market Cap (Dec-25-2022)0.107 Billion USDWorld Rank (Jan-07-2022)16,820Market Cap (Jan-07-2022)0.29 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-24 Million USDAnnual Results for Period EndingDec-2020 ending yearCompany ProfileOlema Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is committed to the discovery, development and commercialization of a transformational generation of targeted therapies for women’s cancers. The headquarters is in USA.Company Website
-
PureTech Health plc
World Rank (Jan-05-2024)10,326Market Cap (Jan-05-2024)0.728 Billion USDWorld Rank (Jul-30-2023)9,828Market Cap (Jul-30-2023)0.812 Billion USDWorld Rank (Dec-25-2022)8,847Market Cap (Dec-25-2022)0.913 Billion USDWorld Rank (Jan-07-2022)8,692Market Cap (Jan-07-2022)1.15 Billion USDAnnual Revenue in USD2 Million USDAnnual Net Income in USD-50 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfilePureTech Health is a Biotechnology company. The headquarters is in USA.Company Website -
Bicycle Therapeutics
World Rank (Jan-05-2024)10,344Market Cap (Jan-05-2024)0.725 Billion USDWorld Rank (Jul-30-2023)9,329Market Cap (Jul-30-2023)0.892 Billion USDWorld Rank (Dec-25-2022)8,977Market Cap (Dec-25-2022)0.891 Billion USDWorld Rank (Jan-07-2022)7,504Market Cap (Jan-07-2022)1.48 Billion USDCompany Website -
ALX Oncology Holdings Inc
World Rank (Jan-05-2024)10,415Market Cap (Jan-05-2024)0.717 Billion USDWorld Rank (Jul-30-2023)16,993Market Cap (Jul-30-2023)0.243 Billion USDWorld Rank (Dec-25-2022)13,048Market Cap (Dec-25-2022)0.454 Billion USDWorld Rank (Jan-07-2022)10,788Market Cap (Jan-07-2022)0.78 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-83 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileALX Oncology is a Clinical Stage Biotechnology company working on Immuno Oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. The company annual revenue is approximately 185.7 million USD. The headquarters is in USA.Company Website -
Calliditas Therapeutics AB
World Rank (Jan-05-2024)10,495Market Cap (Jan-05-2024)0.707 Billion USDWorld Rank (Jul-30-2023)12,880Market Cap (Jul-30-2023)0.490 Billion USDWorld Rank (Dec-25-2022)12,950Market Cap (Dec-25-2022)0.461 Billion USDWorld Rank (Jan-07-2022)12,202Market Cap (Jan-07-2022)0.61 Billion USDCompany Website -
Vera Therapeutics Inc.
World Rank (Jan-05-2024)10,674Market Cap (Jan-05-2024)0.689 Billion USDWorld Rank (Jul-30-2023)10,207Market Cap (Jul-30-2023)0.761 Billion USDWorld Rank (Dec-25-2022)11,799Market Cap (Dec-25-2022)0.550 Billion USDWorld Rank (Jan-07-2022)14,196Market Cap (Jan-07-2022)0.45 Billion USDCompany Website -
Travere Therapeutics Inc.
World Rank (Jan-05-2024)10,719Market Cap (Jan-05-2024)0.683 Billion USDWorld Rank (Jul-30-2023)7,507Market Cap (Jul-30-2023)1.287 Billion USDWorld Rank (Dec-25-2022)7,234Market Cap (Dec-25-2022)1.285 Billion USDWorld Rank (Jan-07-2022)6,953Market Cap (Jan-07-2022)1.70 Billion USDAnnual Revenue in USD212 Million USDAnnual Net Income in USD-278 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileTravere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life changing therapies to people living with rare disease. The headquarters is in USA.
Facts About CompanyTravere Therapeutics Annual Total Revenue for year ending Dec-2022 was 212 million USD and and Net loss for year ending Dec-2022 was -278 million USD.
Travere Therapeutics Annual Total Revenue for year ending Dec-2021 was 227 million USD and and Net loss for year ending Dec-2021 was -180 million USD.
As on 2022, Travere Therapeutics has 462 employees.
Company Website -
Gracell Biotechnologies Inc.
World Rank (Jan-05-2024)10,757Market Cap (Jan-05-2024)0.679 Billion USDWorld Rank (Jul-30-2023)16,436Market Cap (Jul-30-2023)0.271 Billion USDWorld Rank (Dec-25-2022)19,455Market Cap (Dec-25-2022)0.153 Billion USDWorld Rank (Jan-07-2022)16,212Market Cap (Jan-07-2022)0.32 Billion USDCompany Website -
Centessa Pharmaceuticals PLC
World Rank (Jan-05-2024)10,928Market Cap (Jan-05-2024)0.657 Billion USDWorld Rank (Jul-30-2023)10,198Market Cap (Jul-30-2023)0.762 Billion USDWorld Rank (Dec-25-2022)15,498Market Cap (Dec-25-2022)0.310 Billion USDWorld Rank (Jan-07-2022)10,634Market Cap (Jan-07-2022)0.80 Billion USDCompany Website -
Edgewise Therapeutics Inc.
World Rank (Jan-05-2024)11,027Market Cap (Jan-05-2024)0.646 Billion USDWorld Rank (Jul-30-2023)13,494Market Cap (Jul-30-2023)0.444 Billion USDWorld Rank (Dec-25-2022)11,911Market Cap (Dec-25-2022)0.540 Billion USDWorld Rank (Jan-07-2022)10,206Market Cap (Jan-07-2022)0.87 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-42 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileEDGEWISE THERAPEUTICS, INC. is a biotechnology sector company that creates medicines for rare muscle disorders. Headquarters is in USA.Company Website